(NTRA) Natera - Performance 55.8% in 12m
Compare NTRA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
63.17%
#11 in Group
Rel. Strength
91.54%
#647 in Universe
Total Return 12m
55.80%
#22 in Group
Total Return 5y
378.61%
#8 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield 0.34%
81th Percentile in Group
12m Total Return: NTRA (55.8%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: NTRA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NTRA
Total Return (including Dividends) | NTRA | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.06% | -5.85% | -3.01% |
3 Months | -10.83% | -11.95% | -3.15% |
12 Months | 55.80% | -11.00% | 10.19% |
5 Years | 378.61% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | NTRA | XBI | S&P 500 |
1 Month | 25.2% | -59.8% | -5.5% |
3 Months | -71.2% | -70.5% | -58.4% |
12 Months | 89.3% | -6.9% | 84.1% |
5 Years | 27.7% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #53 | 6.28% | 3.16% |
3 Month | #57 | 1.26% | -7.93% |
12 Month | #22 | 75.1% | 41.4% |
5 Years | #8 | 376% | 109% |
FAQs
Does NTRA Natera outperforms the market?
Yes,
over the last 12 months NTRA made 55.80%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months NTRA made -10.83%, while XBI made -11.95%.
Over the last 3 months NTRA made -10.83%, while XBI made -11.95%.
Performance Comparison NTRA vs Indeces and Sectors
NTRA vs. Indices NTRA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.71% | 3.07% | 9.35% | 45.6% |
US NASDAQ 100 | QQQ | -2.73% | 4.12% | 10.1% | 47.2% |
US Dow Jones Industrial 30 | DIA | -3.91% | 2.20% | 8.43% | 46.3% |
German DAX 40 | DAX | -2.41% | 3.44% | -7.44% | 34.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | -3.42% | -0.17% | 24.6% | 46.7% |
Hongkong Hang Seng | HSI | -5.68% | -2.71% | 18.6% | 38.5% |
India NIFTY 50 | INDA | -4.74% | -7.81% | 19.7% | 55.1% |
Brasil Bovespa | EWZ | -3.82% | -8.23% | 17.4% | 67.5% |
NTRA vs. Sectors NTRA is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -2.17% | 3.87% | 1.24% | 36.6% |
Consumer Discretionary | XLY | -4.47% | 3.89% | 5.99% | 41.7% |
Consumer Staples | XLP | -6.50% | 1.90% | 8.51% | 44.8% |
Energy | XLE | -4.80% | -7.96% | 3.77% | 55.0% |
Financial | XLF | -4.19% | 2.76% | -2.81% | 33.6% |
Health Care | XLV | -4.13% | 3.22% | 14.1% | 54.1% |
Industrial | XLI | -4.02% | 0.75% | 10.1% | 47.3% |
Materials | XLB | -4.81% | -0.45% | 17.5% | 59.7% |
Real Estate | XLRE | -5.75% | 2.75% | 12.5% | 42.4% |
Technology | XLK | -2.58% | 4.07% | 14.5% | 53.8% |
Utilities | XLU | -7.0% | -0.76% | 10.2% | 30.6% |
Aerospace & Defense | XAR | -3.11% | -1.22% | 5.43% | 34.9% |
Biotech | XBI | 0.85% | 5.91% | 27.1% | 66.8% |
Homebuilder | XHB | -4.21% | -0.09% | 28.7% | 63.5% |
Retail | XRT | -6.01% | 0.56% | 13.4% | 60.6% |